Options Brief: Elan Corporation, plc

Shares of Elan Corporation, plc ELN are lower on the session by 6.07%, trading at $10.05. Overall call volume is now running at 2.07x the daily average, with 26% of all calls traded being purchases on the offer. 8,931 contracts have traded on the session so far. Elan Corporation, plc is a neuroscience-based biotechnology company. Elan is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases, and in realizing the potential of its scientific discoveries and drug delivery technologies.